The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Sponsor: Georgetown University
Terminated
funding expired
Listed as NCT03063905, this observational or N/A phase trial focuses on Buprenorphine and Pain and remains terminated or withdrawn. Sponsored by Georgetown University, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Status: Recruiting → Terminated · Phase: NA → None
▶ Show 2 earlier versions
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
-
Mar 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Jan 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Georgetown University
- National Institute on Drug Abuse (NIDA)
For direct contact, visit the study record on ClinicalTrials.gov .